| 119.48 Data as of May 17 |  -0.33 / -0.28%Today’s Change | 98.25 Today|||52-Week Range 121.33 | +14.85% Year-to-Date |
| Perrigo Stock Hits New 52-Week High (PRGO) May 15 / TheStreet.com | Earnings Miss at Perrigo - Analyst Blog May 07 / Zacks.com |
| Perrigo Becomes #16 Most Shorted Nasdaq 100 Component, Replacing Intuit May 10 / TheStreet.com | Perrigo Likely to Report In Line Earnings - Analyst Blog May 06 / Zacks.com |
| Previous close | 119.81 |
| Today’s open | 120.32 |
| Day’s range | 119.22 - 120.74 |
| Volume | 493,749 |
| Average volume (3 months) | 515,400 |
| Market cap | $11.2B |
| Dividend yield | 0.30% |
| Earnings growth (last year) | +17.63% |
| Earnings growth (this year) | +12.59% |
| Earnings growth (next 5 years) | +14.50% |
| Revenue growth (last year) | +15.13% |
| P/E ratio | 26.2 |
| Price/Sales | 3.46 |
| Price/Book | 6.03 |
| Today’s change | Today’s % change | |
|---|---|---|
| MYLMylan Inc | +0.70 | +2.28% |
| FRXForest Laboratories ... | -0.17 | -0.44% |
| BMRNBioMarin Pharmaceuti... | -0.49 | -0.76% |
| ONXXOnyx Pharmaceuticals... | +0.30 | +0.31% |
| Next reporting date | August 20, 2013 |
| EPS forecast (this quarter) | $1.58 |
| Annual revenue (last year) | $3.2B |
| Annual profit (last year) | $401.6M |
| Net profit margin | 12.38% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Joseph C. Papa, MBA |
Executive VP-Global Operations & Supply Chain John T. Hendrickson |
Corporate headquarters Allegan, Michigan |
.
